AMI-HYDRO TAB DIN 00870943
Health Canada record
| Active ingredient(s) | AMILORIDE HYDROCHLORIDE 5 MG; HYDROCHLOROTHIAZIDE 50 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | C03EA01 HYDROCHLOROTHIAZIDE AND POTASSIUM-SPARING AGENTS |
| Original market date | 31-Dec-1990 |
| Current status date | 05-May-2017 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing AMILORIDE HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02249510 | MIDAMOR | AA PHARMA INC | Tablet | AMILORIDE HYDROCHLORIDE 5.0 MG | Marketed |
| 02257394 | AMILORIDE HYDROCHLORIDE TABLETS, USP | ORBUS PHARMA INC | Tablet | AMILORIDE HYDROCHLORIDE 5 MG | Cancelled (Unreturned Annual) |
| 00487805 | MIDAMOR TABLETS 5MG | ORBUS PHARMA INC | Tablet | AMILORIDE HYDROCHLORIDE 5 MG | Cancelled Post Market |
| 00487813 | MODURET | PREMPHARM INC | Tablet | AMILORIDE HYDROCHLORIDE 5 MG; HYDROCHLOROTHIAZIDE 50 MG | Cancelled Post Market |
| 02257378 | MYLAN-AMILAZIDE | MYLAN PHARMACEUTICALS ULC | Tablet | AMILORIDE HYDROCHLORIDE 5 MG; HYDROCHLOROTHIAZIDE 50 MG | Cancelled Post Market |
| 01937219 | NOVAMILOR | TEVA CANADA LIMITED | Tablet | AMILORIDE HYDROCHLORIDE 5 MG; HYDROCHLOROTHIAZIDE 50 MG | Cancelled Post Market |
| 02231254 | PENTA-AMILORIDE HCTZ TABLETS | PENTAPHARM LTD. | Tablet | AMILORIDE HYDROCHLORIDE 5 MG; HYDROCHLOROTHIAZIDE 50 MG | Cancelled (Unreturned Annual) |
| 02242092 | RIVA-AMILZIDE 5/50 MG | LABORATOIRE RIVA INC. | Tablet | AMILORIDE HYDROCHLORIDE 5 MG; HYDROCHLOROTHIAZIDE 50 MG | Cancelled Post Market |
International API supply for AMILORIDE HYDROCHLORIDE
1 active FDA Drug Master Files.
Request a quote for AMI-HYDRO TAB